March 13, 2026 · Form 4 insider transaction
Guiheen Lawrence P. bought 30,000 shares of ADMA Biologics, Inc. at $3.66 per share, a transaction worth $109.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; and (ii) 94,830 shares of common stock owned by the Reporting Person.